 Connection
Jorge Saucedo to Adult
This is a "connection" page, showing publications Jorge Saucedo has written about Adult.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.132 |
|
|
|
-
Wayangankar SA, Saucedo JF. Transcatheter coiling of saphenous vein graft to coronary sinus after coronary artery bypass surgery: a case report. J Cardiovasc Med (Hagerstown). 2015 Jan; 16 Suppl 1:S45-8.
Score: 0.037
-
Patel JH, Wayangankar SA, Zacharias S, Stowell D, Saucedo JF. Endovascular repair of traumatic aortic injury: a novel arena in interventional cardiology. J Interv Cardiol. 2013 Feb; 26(1):77-83.
Score: 0.032
-
Saucedo JF, Lui HK, Garza L, Guerra GJ, Jacoski MV, Jennings LK. Comparative pharmacodynamic evaluation of eptifibatide and abciximab in patients with non-ST-segment elevation acute coronary syndromes: the TAM2 study. J Thromb Thrombolysis. 2004 Oct; 18(2):67-74.
Score: 0.018
-
Dasari TW, Saucedo JF, Krim S, Alkhouli M, Fonarow GC, Alvarez R, Ibrahim H, Dai D, Wang TY, Costa M, Lindenfeld J, Messenger JC. Clinical characteristics and in hospital outcomes of heart transplant recipients with allograft vasculopathy undergoing percutaneous coronary intervention: Insights from the National Cardiovascular Data Registry. Am Heart J. 2015 Dec; 170(6):1086-91.
Score: 0.010
-
Hawkins BM, Khan Z, Abu-Fadel MS, Exaire JE, Saucedo JF, Hennebry TA. Endovascular treatment of mesenteric ischemia. Catheter Cardiovasc Interv. 2011 Nov 15; 78(6):948-52.
Score: 0.007
-
Angiolillo DJ, Badimon JJ, Saucedo JF, Frelinger AL, Michelson AD, Jakubowski JA, Zhu B, Ojeh CK, Baker BA, Effron MB. A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial. Eur Heart J. 2011 Apr; 32(7):838-46.
Score: 0.007
-
Grossman PM, Mendelsohn F, Henry TD, Hermiller JB, Litt M, Saucedo JF, Weiss RJ, Kandzari DE, Kleiman N, Anderson RD, Gottlieb D, Karlsberg R, Snell J, Rocha-Singh K. Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease. Am Heart J. 2007 May; 153(5):874-80.
Score: 0.005
-
Rajagopalan S, Mohler E, Lederman RJ, Saucedo J, Mendelsohn FO, Olin J, Blebea J, Goldman C, Trachtenberg JD, Pressler M, Rasmussen H, Annex BH, Hirsch AT. Regional Angiogenesis with Vascular Endothelial Growth Factor (VEGF) in peripheral arterial disease: Design of the RAVE trial. Am Heart J. 2003 Jun; 145(6):1114-8.
Score: 0.004
-
Condado JA, Waksman R, Saucedo JF, Bhargava B, Lansky AJ, Calderas C, Gurdiel O, Gonzalez J, Fadoul M, Parra B, Iturria I, Amezaga B. Five-year clinical and angiographic follow-up after intracoronary iridium-192 radiation therapy. Cardiovasc Radiat Med. 2002 Apr-Jun; 3(2):74-81.
Score: 0.004
-
Zhang Z, Mahoney EM, Gershony G, Ellis S, Saucedo JF, Talley JD, Feldman T, Weintraub WS. Impact of the Duett sealing device on quality of life and hospitalization costs for coronary diagnostic and interventional procedures: Results from the Study of Economic and Quality of Life substudy of the SEAL trial. Am Heart J. 2001 Dec; 142(6):982-8.
Score: 0.004
-
Condado JA, Waksman R, Calderas C, Saucedo J, Lansky A. Two-year follow-up after intracoronary gamma radiation therapy. Cardiovasc Radiat Med. 1999 Jan-Mar; 1(1):30-5.
Score: 0.003
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|